🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Moti Ramgopal

Midway University

ORCID: 0000-0001-7448-1976

Also affiliated with Indian River State College

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study”.

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

The Lancet HIV(2024)10.1016/s2352-3018(23)00293-x
N/A
1.4DataRank · unranked
45 citations

Susan J. Little, Gordon Crofoot, Paul Cook, Peter Ruane, Dushyantha Jayaweera +12 more

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Science Translational Medicine(2021)10.1126/scitranslmed.abg3071
N/A
0DataRank · unranked
78 citations

Cynthia Brinson, Edwin DeJesus, Anthony Mills, Peter Shalit, Susan Guo +19 more

New Proteomic Signatures to Distinguish Between Zika and Dengue Infections

Molecular & Cellular Proteomics(2021)10.1016/j.mcpro.2021.100052
N/A
0DataRank · unranked
17 citations

Shuvadeep Maity, Alice Zhao, Lauren Lashua, Moti Ramgopal, B. Balkaran +8 more

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad101
N/A
0DataRank · unranked
24 citations

Mezgebe Berhe, Tulika Singh, Roberto Ortiz, Anson K Wurapa, Moti Ramgopal +12 more

Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

UNC Libraries(2025)10.17615/jm67-c891
N/A
0DataRank · unranked
0 citations

Anthony Mills, Laurie A. VanderVeen, Paul Cook, Gordon Crofoot, Edwin DeJesus +12 more